Understanding migraine: Potential role of neurogenic inflammation
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Neurogenic inflammation, a well-defined pathophysiologial process is characterized by the release of potent vasoactive neuropeptides, predominantly calcitonin gene-related peptide (CGRP), substance P (SP), and neurokinin A from activated peripheral nociceptive sensory nerve terminals (usually C and A delta-fibers). These peptides lead to a cascade of inflammatory tissue responses including arteriolar vasodilation, plasma protein extravasation, and degranulation of mast cells in their peripheral target tissue. Neurogenic inflammatory processes have long been implicated as a possible mechanism involved in the pathophysiology of various human diseases of the nervous system, respiratory system, gastrointestinal tract, urogenital tract, and skin. The recent development of several innovative experimental migraine models has provided evidence suggestive of the involvement of neuropeptides (SP, neurokinin A, and CGRP) in migraine headache. Antidromic stimulation of nociceptive fibers of the trigeminal nerve resulted in a neurogenic inflammatory response with marked increase in plasma protein extravasation from dural blood vessels by the release of various sensory neuropeptides. Several clinically effective abortive antimigraine medications, such as ergots and triptans, have been shown to attenuate the release of neuropeptide and neurogenic plasma protein extravasation. These findings provide support for the validity of using animal models to investigate mechanisms of neurogenic inflammation in migraine. These also further strengthen the notion of migraine being a neuroinflammatory disease. In the clinical context, there is a paucity of knowledge and awareness among physicians regarding the role of neurogenic inflammation in migraine. Improved understanding of the molecular biology, pharmacology, and pathophysiology of neurogenic inflammation may provide the practitioner the context-specific feedback to identify the novel and most effective therapeutic approach to treatment. With this objective, the present review summarizes the evidence supporting the involvement of neurogenic inflammation and neuropeptides in the pathophysiology and pharmacology of migraine headache as well as its potential significance in better tailoring therapeutic interventions in migraine or other neurological disorders. In addition, we have briefly highlighted the pathophysiological role of neurogenic inflammation in various other neurological disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fibromyalgia and related conditions
Clauw, D. J. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.03.014 · Cited by 259
The serotonergic system in mood disorders and suicidal behaviour
Mann, J. J. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0537 · Cited by 235
Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axis
Assas, B. M., Pennock, J. I., & Miyan, J. A. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00023 · Cited by 226
Research works printed but not linked: 81
- Smitherman, 2013, The prevalence, impact, and treatment of migraine and severe headaches in the United States: A review of statistics from national surveillance studies, Headache, 427
- Wolff HG. Headache and Other Head Pain. New York: Oxford University Press; 1963.
- Buzzi, 2005, The pathophysiology of migraine: Year 2005, J Headache Pain, 105
- Burgos-Vega, 2015, Meningeal afferent signaling and the pathophysiology of migraine, Prog Mol Biol Transl Sci, 537
- Bayliss, 1901, On the origin from the spinal cord of the vaso-dilator fibers of the hind limb, and on the nature of these fibers, J Physiol, 173
- Geppetti, 2012, Antidromic vasodilatation and the migraine mechanism, J Headache Pain, 103
- Olivar, 2000, Neurogenic vasodilation in rabbit basilar isolated artery: Involvement of calcitonin-gene related peptide, Eur J Pharmacol, 61
- Miyoshi, 1995, Calcitonin gene-related peptide activates the K+ channels of vascular smooth muscle cells via adenylate cyclase, Basic Res Cardiol, 332
- Bellamy, 2006, Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons, Eur J Neurosci, 2057
- Gibbins, 1985, Co-localization of calcitonin gene-related peptide-like immunoreactivity with substance P in cutaneous, vascular and visceral sensory neurons of guinea pigs, Neurosci Lett, 125
- Tam, 2004, The assessment of vasoactive properties of CGRP and adrenomedullin in the microvasculature: A study using in vivo and in vitro assays in the mouse, J Mol Neurosci, 117
- Hunt SP, O'Brien JA, Palmer JA. Role of substance P in nociception, analgesia, and aggression. In: Wood JN, editor. Molecular Basis of Pain Induction. New York: John Wiley & Sons; 2000. p. 209-60.
- Durham, 2004, CGRP-receptor antagonists — a fresh approach to migraine therapy?, N Engl J Med, 1073
- van, 1997, Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors, Neurosci Biobehav Rev, 649
- Zagami, 1990, Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides, Neuropeptides, 69
- Goadsby, 2004, Vasoactive peptide release in the extracerebral circulation of humans during migraine headache, Ann Neurol, 183
- Regoli, 1994, Receptors and antagonists for substance P and related peptides, Pharmacol Rev, 551
- Gasporovic, 1964, Contribution to the theory that substance P has a transmitter role in sensitive pathway, Med Exp Int J Exp Med, 303
- Battaglia, 1988, Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey, J Comp Neurol, 302
- Liu, 1997, NMDA-receptor regulation of substance P release from primary afferent nociceptors, Nature, 721
- Rosa, 2013, The role of histamine in neurogenic inflammation, Br J Pharmacol, 38
- Williamson, 1997, Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat, Cephalalgia, 518
- Alvaro, 2007, Neurokinin 1 receptor antagonists — current prospects, Curr Opin Drug Discov Devel, 613
- Hoyer, 1997, 5-HT receptor classification and nomenclature: Towards a harmonization with the human genome, Neuropharmacology, 419
- Johnson, 1998, Serotonin in migraine: Theories, animal models and emerging therapies, Prog Drug Res, 219
- Durham, 1997, Repression of the calcitonin gene-related peptide promoter by 5-HT1 receptor activation, J Neurosci, 9545
- Buzzi, 1990, The antimigraine drug, sumatriptan (GR43175) selectively blocks neurogenic plasma extravasation from blood vessels in dura matter, Br J Pharmacol, 202
- Cutrer, 1999, Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis, Neuropharmacology, 1043
- Schmitz, 2015, BF-1—a novel selective 5-HT2B receptor antagonist blocking neurogenic dural plasma protein extravasation in guinea pigs, Eur J Pharmacol, 73
- Manivet, 2000, PDZ-dependent activation of nitric-oxide synthases by the serotonin 2B receptor, J Biol Chem, 9324
- Yonehara, 1999, Effect of nitric oxide on substance P release from the peripheral endings of primary afferent neurons, Neurosci Lett, 199
- Bonhaus, 1999, RS-127445: A selective, high affinity, orally bioavailable 5-HT2B receptor antagonist, Br J Pharmacol, 1075
- Terrón, 2002, Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine?, Eur J Pharmacol, 1
- Bennett, 2001, Neurotrophic factors: Important regulators of nociceptive function, Neuroscientist, 13
- Amaya, 2004, NGF and GDNF differentially regulate TRPV1 expression that contributes to development of inflammatory thermal hyperalgesia, Eur J Neurosci, 2303
- Saldanha, 1999, Decreased CGRP, but preserved Trk A immunoreactivity in nerve fibers in inflamed human superficial temporal arteries, J Neurol Neurosurg Psychiatry, 390
- Price, 2005, Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: Effects on neuronal survival, neurchemial properties and TRVP1-medated neuropeptide secretion, BMC Neurosci, 4
- Amann, 1996, Intraplantar injection of nerve growth factor into the rat hind paw: Local edema and effects on thermal nociceptive threshold, Pain, 323
- Schicho, 1999, Regeneration effect of human recombinant NGF on capsaicin-lesioned sensory neurons in the adult rat, Brain Res, 60
- Martins, 2015, Migraine is associated with altered levels of neurotrophins, Neurosci Lett, 6
- Bredt, 1999, Endogenous nitric oxide synthesis: Biological functions and pathophysiology, Free Radic Res, 577
- Szabó, 1996, Physiological and pathophysiological roles of nitric oxide in the central nervous system, Brain Res Bull, 131
- Olesen, 2008, The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache, Pharmacol Ther, 157
- Johnson, 2003, Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation, Cephalalgia, 117
- Ramachandran, 2014, Nitric oxide synthase, calcitonin gene-related peptide and NK-1 receptor mechanisms are involved in GTN-induced neuronal activation, Cephalalgia, 136
- Klede, 2003, The effect of the nitric oxide synthase inhibitor N-nitro-L-arginine-methyl ester on neuropeptide-induced vasodilation and protein extravasation in human skin, J Vasc Res, 105
- Guldiken, 2009, Asymmetric dimethylarginine and nitric oxide levels in migraine during the interictal period, J Clin Neurosci, 672
- Smith, 1991, Prostaglandin and thromboxane biosynthesis, Pharmacol Ther, 153
- Hingtgen, 1995, Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3',5'-cyclic monophosphate transduction cascade, J Neurosci, 5411
- Ebersberger, 1999, Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro, Neuroscience, 901
- Schuh-Hofer, 2006, Effects of parecoxib on plasma protein extravasation and c-fos expression in the rat, Headache, 276
- Bormann, 2000, The 'ABC' of GABA receptors, Trends Pharmacol Sci, 16
- Welch, 1975, Cerebrospinal fluid gamma aminobutyric acid levels in migraine, Br Med J, 516
- Linde, 2013, Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults, Cochrane Database Syst Rev, CD010611
- Guennoun, 2015, Progesterone and allopregnanolone in the central nervous system: Response to injury and implication for neuroprotection, J Steroid Biochem Mol Biol, 48
- Hou, 2002, Capsaicin receptor immunoreactivity in the human trigeminal ganglion, Neurosci Lett, 223
- Akerman, 2003, Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation, Br J Pharmacol, 718
- Rapoport, 2004, Intranasal medications for the treatment of migraine and cluster headache, CNS Drugs, 671
- Jakubowicz, 2010, Complex regional pain syndrome/reflex sympathetic dystrophy, J Pain Palliat Care Pharmacother, 160
- Weber, 2001, Facilitated neurogenic inflammation in complex regional pain syndrome, Pain, 251
- Leis, 2004, Facilitated neurogenic inflammation in unaffected limbs of patients with complex regional pain syndrome, Neurosci Lett, 163
- Kingery, 2003, A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II, Pain, 75
- Staud, 2002, Peripheral and central sensitization in fibromyalgia: Pathogenetic role, Curr Pain Headache Rep, 259
- De, 2000, Image analysis quantification of substance P immunoreactivity in the trapezius muscle of patients with fibromyalgia and myofacial pain syndrome, J Rheumatol, 2906
- Vaeroy, 1988, Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: New features for diagnosis, Pain, 21
- Corrigan F, Vink R, Turner RJ. Inflammation in acute CNS injury: A focus on the role of substance P. Br J Pharmacol 2015. [Epub ahead of print]. · DOI
- Kiani, 2015, A randomized clinical trial of efficacy and safety of the topical clonidine and capsaicin in the treatment of painful diabetic neuropathy, J Res Med Sci, 359
- Olesen, 2004, ; BIBN 4096 BS Clinical Proof of Concept Study Group.Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine, N Engl J Med, 1104
- Phebus, 1997, The non-peptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigs, Life Sci, 1553
- Norman, 1998, A placebo-controlled, in-clinic study to explore the preliminary safety and efficacy of intravenous L-758,298 (a prodrug of the NK1 receptor antagonist L-754,030) in the acute treatment of migraine, Cephalalgia, 407
- Polley, 1997, The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular system, Regul Pept, 23
- Ashina, 2002, Nitric oxide synthase inhibitors for the treatment of chronic tension-type headache, Expert Opin Pharmacother, 395
- Shepheard, 1999, Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370, Cephalalgia, 851
- Earl, 1999, Efficacy and tolerability of the neurogenic inflammation inhibitor, 4991W93, in the acute treatment of migraine, Cephalalgia, 357
- Gomez-Mantilla, 2001, Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine, Cephalalgia, 727
- Brändli, 1996, Role of endothelin in mediating neurogenic plasma extravasation in rat dura mater, Pain, 315
- Evers, 2004, Botulinum toxin A in the prophylactic treatment of migraine — a randomized, double-blind, placebo-controlled study, Cephalalgia, 838
- Morris, 2001, Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons, Am J Physiol Heart Circ Physiol, H2124
- Tugnoli, 2007, Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin, Pain, 76
- Liberopoulos, 2006, Could statins be useful in the treatment of patients with migraine?, Headache, 672
- Kim, 2007, Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model, Eur J Pharmacol, 76
Cited by
The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders
Knezevic, E., Nenic, K., Milanovic, V., & Knezevic, N. N. (2023) · Cells · doi:10.3390/cells12232726 · Cited by 564
“Sensitized meningeal afferents innervating the dural vasculature are implicated in migraine pathophysiology, with these afferents projecting to the nucleus caudalis in the trigeminal ganglion [41].”
BackgroundCOVID-19 and multiorgan failure: A narrative review on potential mechanisms
Mokhtari, T., Hassani, F., Ghaffari, N., Ebrahimi, B., Yarahmadi, A., & Hassanzadeh, G. (2020) · Journal of Molecular Histology · doi:10.1007/s10735-020-09915-3 · Cited by 439
Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine
Lombardo, S., Mazzon, E., Basile, M., Cavalli, E., Bramanti, P., Nania, R., Fagone, P., Nicoletti, F., & Petralia, M. (2019) · Brain Sciences · doi:10.3390/brainsci9070172 · Cited by 33
“Accordingly, inhibition of the dural neurogenic inflammation with molecules able to inhibit the pathways involved in the activation and sensitization of trigeminovascular neurons—at both their central and peripheral perivascular nerve endings—have been tested as potential therapeutic strategies in the treatment of mig…”
Background
Metadata
- Authors
- Malhotra, R.
- Venue
- Annals of Indian Academy of Neurology
- Publisher
- Medknow
- Published
- 2016
- Volume
- 19
- Issue
- 2
- Pages
- 175
- ISSN
- 0972-2327 (ISSN-L)
- OpenAlex
- W2390524195
- Cited by
- 162
- References
- 3
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Understanding migraine: Potential role of neurogenic inflammation. https://app.cochat.ai/papers/10.4103/0972-2327.182302
- The paper
- Malhotra, R. (2016). Understanding migraine: Potential role of neurogenic inflammation. Annals of Indian Academy of Neurology. https://doi.org/10.4103/0972-2327.182302
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.